Ideal Cures gets US patent for pharma coating technology (With Images)March 27th, 2012 - 2:00 pm ICT by IANS
Mumbai, March 27 (IANS) Ideal Cures, a company specialising in film coating compositions on tablets, pellets and granules for the pharma, health and dietary supplement industry, has secured a US patent for an innovation, claimed as both cost-effective and non-toxic.
“This provides an excellent opportunity to pharma and nutraceuticals industry worldwide to get rid of organic solvents like isopropyl alcohol and methylene chloride, toxic to environment and coating operators,” said Ideal Cures Managing Director Suresh Pareek.
“Inventive composition provides elegant, glossy, prompt-release coating which does not retard release of active ingredient from coated substrate,” Pareek said, explaining the technology and material used for covering and protecting products like tablets.
“This is the first time an Indian pharmaceutical excipient manufacturer has been granted a US patent on a ready-to-use film coating composition. This raises our patent portfolio to 10 now — nine of which have been granted in India.”
Pareek is also a co-inventor of the new technology.
Going into the technical aspects of the innovation that has secured the US Patent Number 8,123,849, experts at Ideal Cures said it uses a coating composition, comprising sodium alginate with 20 percent recon level.
“This will result in saving of up to 40 percent in coating time for pharmaceuticals and nutraceutical industry, compared with other compositions based on hydroxy-propyl-methyl-cellulose,” said one of the scientists at the Ideal Cures facility here.
This technology also protects tablets from moisture, sunlight and some other atmospheric conditions, and would also be of great help to nutraceutical companies, which make food products that provide both health and medical benefits, the scientist said.
This apart, addition of colours in the composition would have the distinct advantage of creating brand identification for the user and add smoothness in finish that will help in easy passage of the tablets, even bigger ones, through the esophagus, he added.
The company has also filed for a single patent under the Patent Cooperation Treaty for an application based on a sodium alginate for a programmed timed release of active ingredients with pre-determined lag period.
This is useful for acidic ingredients and in cases where there is stomach degradation.
According to scientists at Ideal Cures, they are offering tomorrow’s technology today, while others are struggling to develop similar products based on natural polymers which will qualify for “Gras” — or generally recognised as safe — status.
The company, headquartered in Mumbai, has a presence in more than 40 countries. It has a subsidiary company in Europe, and three plants at Vasai, near Mumbai, Jammu and Khambhat in Gujarat, all of which are covered by cGMP - current good manufacturing practices.
It has been pursuing tailor-made excipients and coating solutions for solid dosage forms such as ready-to-use coating systems, modified release technologies, novel drug delivery systems, acrylic pharma polymers, extended cooling boosters and neutral spheres.
- Ideal Cures to launch new tablet coating product in Geneva - May 21, 2012
- Ideal Cures unveil new technology to prolong drug release - Jul 23, 2012
- Dairy giant buys Indian pharmaceutical firm - Aug 31, 2011
- Japanese firms eye India with pills to keep you young, healthy - Aug 29, 2011
- Nutraceuticals in energy drinks, foods - Mar 20, 2011
- Apple applies for iPad Smart Cover patent - Aug 03, 2012
- Patents law provisions conflicting, Novartis tells SC - Sep 18, 2012
- Elder Pharma to sell Indian brands in European market - Jun 07, 2011
- RIM ties up with Dolby for its audio technology - Sep 13, 2011
- 'Nothing natural about 'Natural Viagra' being sold online' - May 03, 2011
- Microsoft's 'tactile' app 'could spell end of mobile keypads' - Nov 27, 2010
- Unique coating kills 99 percent bugs - May 11, 2012
- US Supreme Court hears Microsoft appeal on Word patent - Apr 18, 2011
- Microsoft reaches patent deal with LG - Jan 13, 2012
- Now plastic from milk protein and clay - Oct 21, 2010
Tags: active ingredient, atmospheric conditions, coating composition, coating technology, company specialising, dietary supplement industry, distinct advantage, excipient, film coating, granules, medical benefits, methyl cellulose, number 8, nutraceuticals industry, organic solvents, patent portfolio, protecting products, smoothness, sodium alginate, us patent number